| Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion R Straussman, T Morikawa, K Shee, M Barzily-Rokni, ZR Qian, J Du, ... Nature 487 (7408), 500-504, 2012 | 1946 | 2012 |
| Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine LT Geller, M Barzily-Rokni, T Danino, OH Jonas, N Shental, D Nejman, ... Science 357 (6356), 1156-1160, 2017 | 1296 | 2017 |
| P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer LM Dillon, JR Bean, W Yang, K Shee, LK Symonds, JM Balko, ... Oncogene 34 (30), 3968-3976, 2015 | 84 | 2015 |
| Therapeutically targeting tumor microenvironment–mediated drug resistance in estrogen receptor–positive breast cancer K Shee, W Yang, JW Hinds, RA Hampsch, FS Varn, NA Traphagen, ... Journal of Experimental Medicine 215 (3), 895-910, 2018 | 68 | 2018 |
| AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells RA Hampsch, JD Wells, NA Traphagen, CF McCleery, JL Fields, K Shee, ... Clinical Cancer Research 26 (14), 3707-3719, 2020 | 60 | 2020 |
| Cell competition during growth and regeneration R Gogna, K Shee, E Moreno Annual review of genetics 49, 697-718, 2015 | 54 | 2015 |
| Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer ML Axelrod, MJ Nixon, PI Gonzalez-Ericsson, RE Bergman, MA Pilkinton, ... Clinical Cancer Research 26 (21), 5668-5681, 2020 | 49 | 2020 |
| The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53 E Madan, TM Parker, MR Bauer, A Dhiman, CJ Pelham, M Nagane, ... Journal of Biological Chemistry 293 (12), 4262-4276, 2018 | 40 | 2018 |
| Tumor microenvironment induces innate RAF-inhibitor resistance through HGF secretion R Straussman, T Morikawa, K Shee, M Barzily-Rokni, ZR Qian, J Du, ... Nature 487 (7408), 500, 2012 | 40 | 2012 |
| Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging … K Shee, JD Wells, A Jiang, TW Miller PLoS One 14 (11), e0224267, 2019 | 36 | 2019 |
| Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer RA Hampsch, K Shee, D Bates, LD Lewis, L Désiré, B Leblond, ... Oncotarget 8 (13), 21806, 2017 | 35 | 2017 |
| Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer W Yang, SR Hosford, LM Dillon, K Shee, SC Liu, JR Bean, L Salphati, ... Clinical Cancer Research 22 (9), 2250-2260, 2016 | 34 | 2016 |
| Perspectives in primary hyperoxaluria—historical, current and future clinical interventions K Shee, ML Stoller Nature Reviews Urology 19 (3), 137-146, 2022 | 27 | 2022 |
| Pain management in penile prosthetic surgery: a review of the literature L Reinstatler, K Shee, MS Gross Sexual medicine reviews 6 (1), 162-169, 2018 | 27 | 2018 |
| Autophagy promotes escape from phosphatidylinositol 3-kinase inhibition in estrogen receptor–positive breast cancer W Yang, SR Hosford, NA Traphagen, K Shee, E Demidenko, S Liu, ... The FASEB Journal 32 (3), 1222, 2018 | 25 | 2018 |
| A novel ex vivo trainer for robotic vesicourethral anastomosis K Shee, K Koo, X Wu, FM Ghali, RJ Halter, ES Hyams Journal of robotic surgery 14, 21-27, 2020 | 21 | 2020 |
| Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer SR Hosford, K Shee, JD Wells, NA Traphagen, JL Fields, RA Hampsch, ... Molecular oncology 13 (8), 1778-1794, 2019 | 21 | 2019 |
| Formal mentorship as an opportunity to expand the urology pipeline: under represented trainees entering residency (UReTER) program evaluation 2020–2021 MY Zheng, M Overland, D Escobar, M Fakunle, Y Li, C Chu, ... Urology 162, 108-113, 2022 | 20 | 2022 |
| Ductal carcinoma in situ biomarkers in a precision medicine era: current and future molecular-based testing K Shee, KE Muller, J Marotti, TW Miller, WA Wells, GJ Tsongalis The American Journal of Pathology 189 (5), 956-965, 2019 | 19 | 2019 |
| Readability analysis of online health information about overactive bladder K Koo, K Shee, RL Yap Neurourology and Urodynamics 36 (7), 1782-1787, 2017 | 18 | 2017 |
Todd W. MillerAssociate Professor of Molecular & Systems Biology, Geisel School of Medicine at DartmouthVerified email at dartmouth.edu
